Figure 1.
Patient classification at baseline and after 2 years follow up according to 2010 ACR/EULAR criteria, and according to outcome after 2 years follow up.
Table 1.
Baseline patient characteristics.
Figure 2.
Synovial tissue expression of different cellular markers.
Synovial tissue expression of, CD55+ fibroblast-like synoviocytes (FLS), CD3+ T CD68+ macrophages, CD3+ T cells, CD22+ B cells, CD138+ plasma cells. A:RA patient according to the 1987 ACR criteria, B:RA patient according to the 2010 ACR/EULAR criteria.
Table 2.
Expression of synovial phenotypic and vascular markers in patients who fulfilled 2010 ACR/EULAR criteria for RA at baseline after follow up and in the patients who fulfilled1987 ACR criteria.
Table 3.
Expression of synovial phenotypic and vascular markers in patients who fulfilled 2010 ACR/EULAR criteria for RA at baseline subclassified according to fulfillment of 1987 ACR criteria at baseline and after follow up.
Table 4.
Expression of phenotypic and vascular markers in synovial tissue of RA patients with self-limiting, persistent non-erosive or persistent erosive disease.